RadNet, Inc. (RDNT)
USD 72.41
(-5.37%)
USD 72.41
(-5.37%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.61 Billion USD | 13.05% |
| 2022 | 1.43 Billion USD | 8.74% |
| 2021 | 1.31 Billion USD | 22.69% |
| 2020 | 1.07 Billion USD | -7.13% |
| 2019 | 1.15 Billion USD | 18.36% |
| 2018 | 975.14 Million USD | 5.74% |
| 2017 | 922.18 Million USD | 4.26% |
| 2016 | 884.53 Million USD | 9.25% |
| 2015 | 809.62 Million USD | 12.83% |
| 2014 | 717.56 Million USD | 2.07% |
| 2013 | 702.98 Million USD | 8.63% |
| 2012 | 647.15 Million USD | 4.41% |
| 2011 | 619.8 Million USD | 12.99% |
| 2010 | 548.53 Million USD | 4.61% |
| 2009 | 524.36 Million USD | 4.43% |
| 2008 | 502.11 Million USD | 18.01% |
| 2007 | 425.47 Million USD | 164.26% |
| 2006 | 161 Million USD | 10.6% |
| 2005 | 145.57 Million USD | 6.04% |
| 2004 | 137.27 Million USD | -2.13% |
| 2003 | 140.25 Million USD | 0.7% |
| 2002 | 139.28 Million USD | 24.54% |
| 2001 | 111.83 Million USD | 27.14% |
| 2000 | 87.96 Million USD | 21.67% |
| 1999 | 72.3 Million USD | 22.92% |
| 1998 | 58.82 Million USD | -12.23% |
| 1997 | 67.01 Million USD | 18.54% |
| 1996 | 56.53 Million USD | 24.69% |
| 1995 | 45.34 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 431.7 Million USD | 2.69% |
| 2024 Q2 | 459.71 Million USD | 6.49% |
| 2023 FY | 1.61 Billion USD | 13.05% |
| 2023 Q1 | 390.56 Million USD | 1.74% |
| 2023 Q3 | 401.96 Million USD | -0.43% |
| 2023 Q4 | 420.38 Million USD | 4.58% |
| 2023 Q2 | 403.71 Million USD | 3.37% |
| 2022 Q2 | 354.37 Million USD | 3.69% |
| 2022 Q4 | 383.87 Million USD | 9.66% |
| 2022 Q3 | 350.04 Million USD | -1.22% |
| 2022 FY | 1.43 Billion USD | 8.74% |
| 2022 Q1 | 341.76 Million USD | 2.59% |
| 2021 Q4 | 333.14 Million USD | 0.14% |
| 2021 Q1 | 315.31 Million USD | 2.21% |
| 2021 Q2 | 333.91 Million USD | 5.9% |
| 2021 FY | 1.31 Billion USD | 22.69% |
| 2021 Q3 | 332.69 Million USD | -0.37% |
| 2020 Q4 | 308.5 Million USD | 5.73% |
| 2020 Q3 | 291.77 Million USD | 53.11% |
| 2020 Q2 | 190.56 Million USD | -32.32% |
| 2020 FY | 1.07 Billion USD | -7.13% |
| 2020 Q1 | 281.56 Million USD | -6.41% |
| 2019 Q3 | 292.69 Million USD | 1.24% |
| 2019 Q2 | 289.09 Million USD | 6.46% |
| 2019 Q1 | 271.54 Million USD | 5.57% |
| 2019 FY | 1.15 Billion USD | 18.36% |
| 2019 Q4 | 300.84 Million USD | 2.78% |
| 2018 Q4 | 257.21 Million USD | 6.22% |
| 2018 FY | 975.14 Million USD | 5.74% |
| 2018 Q1 | 231.39 Million USD | -1.77% |
| 2018 Q2 | 244.39 Million USD | 5.62% |
| 2018 Q3 | 242.14 Million USD | -0.92% |
| 2017 Q2 | 230.01 Million USD | 0.44% |
| 2017 Q4 | 235.55 Million USD | 3.49% |
| 2017 Q3 | 227.6 Million USD | -1.05% |
| 2017 Q1 | 229.01 Million USD | 1.81% |
| 2017 FY | 922.18 Million USD | 4.26% |
| 2016 FY | 884.53 Million USD | 9.25% |
| 2016 Q1 | 216.38 Million USD | 0.32% |
| 2016 Q2 | 218.56 Million USD | 1.01% |
| 2016 Q3 | 224.64 Million USD | 2.78% |
| 2016 Q4 | 224.93 Million USD | 0.13% |
| 2015 FY | 809.62 Million USD | 12.83% |
| 2015 Q2 | 204.28 Million USD | 12.7% |
| 2015 Q3 | 208.36 Million USD | 2.0% |
| 2015 Q4 | 215.7 Million USD | 3.52% |
| 2015 Q1 | 181.26 Million USD | -2.31% |
| 2014 Q2 | 179.08 Million USD | 6.04% |
| 2014 Q1 | 168.87 Million USD | -5.31% |
| 2014 FY | 717.56 Million USD | 2.07% |
| 2014 Q4 | 185.55 Million USD | 0.81% |
| 2014 Q3 | 184.05 Million USD | 2.78% |
| 2013 Q1 | 172.94 Million USD | 8.54% |
| 2013 FY | 702.98 Million USD | 8.63% |
| 2013 Q4 | 178.33 Million USD | 1.8% |
| 2013 Q2 | 176.52 Million USD | 2.07% |
| 2013 Q3 | 175.18 Million USD | -0.75% |
| 2012 Q4 | 159.33 Million USD | -0.7% |
| 2012 Q1 | 162.01 Million USD | -3.05% |
| 2012 Q2 | 165.35 Million USD | 2.06% |
| 2012 Q3 | 160.45 Million USD | -2.96% |
| 2012 FY | 647.15 Million USD | 4.41% |
| 2011 Q2 | 155.63 Million USD | 6.44% |
| 2011 FY | 619.8 Million USD | 12.99% |
| 2011 Q4 | 167.1 Million USD | 10.78% |
| 2011 Q3 | 150.84 Million USD | -3.08% |
| 2011 Q1 | 146.21 Million USD | 0.62% |
| 2010 FY | 548.53 Million USD | 4.61% |
| 2010 Q3 | 140.09 Million USD | 0.82% |
| 2010 Q1 | 124.17 Million USD | -5.79% |
| 2010 Q2 | 138.95 Million USD | 11.9% |
| 2010 Q4 | 145.31 Million USD | 3.73% |
| 2009 Q2 | 131.14 Million USD | 2.46% |
| 2009 FY | 524.36 Million USD | 4.43% |
| 2009 Q1 | 128 Million USD | -0.2% |
| 2009 Q4 | 131.81 Million USD | -1.19% |
| 2009 Q3 | 133.4 Million USD | 1.72% |
| 2008 Q2 | 127.44 Million USD | 11.11% |
| 2008 FY | 502.11 Million USD | 18.01% |
| 2008 Q3 | 131.71 Million USD | 3.35% |
| 2008 Q4 | 128.25 Million USD | -2.63% |
| 2008 Q1 | 114.69 Million USD | 11.99% |
| 2007 Q2 | 107.02 Million USD | 1.15% |
| 2007 FY | 425.47 Million USD | 164.26% |
| 2007 Q1 | 105.81 Million USD | 0.0% |
| 2007 Q3 | 110.2 Million USD | 2.97% |
| 2007 Q4 | 102.41 Million USD | -7.07% |
| 2006 FY | 161 Million USD | 10.6% |
| 2006 Q2 | 40.33 Million USD | 1.89% |
| 2006 Q1 | 39.58 Million USD | 2.72% |
| 2006 Q3 | 42.54 Million USD | 5.47% |
| 2005 Q2 | 36.17 Million USD | 2.81% |
| 2005 Q4 | 38.53 Million USD | -3.88% |
| 2005 Q1 | 35.19 Million USD | 3.17% |
| 2005 FY | 145.57 Million USD | 6.04% |
| 2005 Q3 | 40.09 Million USD | 10.83% |
| 2004 Q2 | 33.9 Million USD | -5.45% |
| 2004 FY | 137.27 Million USD | -2.13% |
| 2004 Q4 | 34.11 Million USD | 1.89% |
| 2004 Q1 | 35.85 Million USD | 5.3% |
| 2004 Q3 | 33.47 Million USD | -1.25% |
| 2003 Q2 | 36.34 Million USD | 1.27% |
| 2003 Q3 | 32.28 Million USD | -11.15% |
| 2003 Q4 | 34.04 Million USD | 5.45% |
| 2003 Q1 | 35.88 Million USD | 0.39% |
| 2003 FY | 140.25 Million USD | 0.7% |
| 2002 Q3 | 37.53 Million USD | 5.5% |
| 2002 Q4 | 35.74 Million USD | -4.77% |
| 2002 FY | 139.28 Million USD | 24.54% |
| 2002 Q1 | 33.72 Million USD | 3.95% |
| 2002 Q2 | 35.58 Million USD | 5.51% |
| 2001 Q2 | 29.46 Million USD | 12.87% |
| 2001 Q4 | 32.44 Million USD | 0.88% |
| 2001 Q3 | 32.15 Million USD | 9.15% |
| 2001 Q1 | 26.1 Million USD | 8.27% |
| 2001 FY | 111.83 Million USD | 27.14% |
| 2000 Q2 | 23.41 Million USD | 6.91% |
| 2000 Q1 | 21.9 Million USD | 9.51% |
| 2000 FY | 87.96 Million USD | 21.67% |
| 2000 Q4 | 24.11 Million USD | 6.37% |
| 2000 Q3 | 22.66 Million USD | -3.2% |
| 1999 Q1 | 18.7 Million USD | 16.88% |
| 1999 Q3 | 18.6 Million USD | -1.59% |
| 1999 FY | 72.3 Million USD | 22.92% |
| 1999 Q2 | 18.9 Million USD | 1.07% |
| 1999 Q4 | 20 Million USD | 7.53% |
| 1998 Q3 | 12.9 Million USD | -19.38% |
| 1998 Q2 | 16 Million USD | 1.91% |
| 1998 Q4 | 16 Million USD | 24.03% |
| 1998 FY | 58.82 Million USD | -12.23% |
| 1998 Q1 | 15.7 Million USD | 9.79% |
| 1997 Q2 | 17.5 Million USD | 0.57% |
| 1997 Q3 | 14.5 Million USD | -17.14% |
| 1997 Q4 | 14.3 Million USD | -1.38% |
| 1997 FY | 67.01 Million USD | 18.54% |
| 1997 Q1 | 17.4 Million USD | -1.14% |
| 1996 FY | 56.53 Million USD | 24.69% |
| 1996 Q3 | 16.6 Million USD | 30.71% |
| 1996 Q2 | 12.7 Million USD | -5.93% |
| 1996 Q1 | 13.5 Million USD | 0.0% |
| 1996 Q4 | 17.6 Million USD | 6.02% |
| 1995 FY | 45.34 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Bionano Genomics, Inc. | 36.11 Million USD | -4376.216% |
| Prenetics Global Limited | 21.74 Million USD | -7335.286% |
| Star Equity Holdings, Inc. | 45.78 Million USD | -3430.916% |
| CareDx, Inc | 280.32 Million USD | -476.701% |
| Exact Sciences Corporation | 2.49 Billion USD | 35.329% |
| Exagen Inc. | 52.54 Million USD | -2976.482% |
| Inotiv, Inc. | 572.42 Million USD | -182.418% |
| Guardant Health, Inc. | 563.94 Million USD | -186.663% |
| Biodesix, Inc. | 49.08 Million USD | -3193.397% |
| BioNexus Gene Lab Corp. | 9.77 Million USD | -16445.513% |
| Precipio, Inc. | 15.19 Million USD | -10537.823% |
| iSpecimen Inc. | 9.92 Million USD | -16183.24% |
| Natera, Inc. | 1.08 Billion USD | -49.332% |
| Aspira Women's Health Inc. | 9.15 Million USD | -17560.367% |
| Standard BioTools Inc. | 106.34 Million USD | -1420.246% |
| 23andMe Holding Co. | 219.63 Million USD | -636.043% |
| Castle Biosciences, Inc. | 219.78 Million USD | -635.541% |
| Personalis, Inc. | 73.48 Million USD | -2100.065% |
| Aclaris Therapeutics, Inc. | 31.24 Million USD | -5073.382% |
| Applied DNA Sciences, Inc. | 13.36 Million USD | -11993.786% |
| OpGen, Inc. | 3.41 Million USD | -47193.115% |
| T2 Biosystems, Inc. | 7.19 Million USD | -22375.045% |
| Myriad Genetics, Inc. | 678.4 Million USD | -138.3% |
| ICON Public Limited Company | 8.12 Billion USD | 80.091% |
| NeoGenomics, Inc. | 591.64 Million USD | -173.244% |
| Star Equity Holdings, Inc. | 45.78 Million USD | -3430.916% |
| IDEXX Laboratories, Inc. | 3.66 Billion USD | 55.841% |
| MDxHealth SA | 70.19 Million USD | -2203.121% |
| Psychemedics Corporation | 22.09 Million USD | -7215.73% |
| Illumina, Inc. | 4.5 Billion USD | 64.107% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Twist Bioscience Corporation | 312.97 Million USD | -416.538% |
| DarioHealth Corp. | 20.35 Million USD | -7843.347% |
| Fulgent Genetics, Inc. | 289.21 Million USD | -458.976% |
| Sera Prognostics, Inc. | 306 Thousand USD | -528210.458% |
| ENDRA Life Sciences Inc. | - USD | -Infinity% |
| OPKO Health, Inc. | 863.49 Million USD | -87.219% |
| Medpace Holdings, Inc. | 1.88 Billion USD | 14.275% |
| Neogen Corporation | 924.22 Million USD | -74.918% |
| Intelligent Bio Solutions Inc. | 3.11 Million USD | -51851.921% |
| Prenetics Global Limited | 21.74 Million USD | -7335.286% |
| Mainz Biomed B.V. | 895.47 Thousand USD | -180432.43% |
| bioAffinity Technologies, Inc. | 2.53 Million USD | -63735.366% |
| Trinity Biotech plc | 56.83 Million USD | -2744.577% |
| Neuronetics, Inc. | 71.34 Million USD | -2165.838% |
| Sotera Health Company | 1.04 Billion USD | -54.069% |
| bioAffinity Technologies, Inc. | 2.53 Million USD | -63735.366% |